Robert Lodder
University of Kentucky
H-index: 34
North America-United States
Top articles of Robert Lodder
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Screening for quality with process analytical technology in a health-system pharmacy: A primer | American Journal of Health-System Pharmacy | Philip J Almeter James T Isaacs Aaron N Hunter Thomas A Lyman Stephanie P Zapata | 2024/2/1 |
Spectral intra-lot and inter-lot variability in carfilzomib | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2023 |
Spectrometric Assessment of Generic and Brand Drug Quality for a Sentinel Screening Network | Applied Spectroscopy | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2023/8/1 |
Assessment of Vecuronium Quality Using Near-Infrared Spectrometry | Contact in context | James T Isaacs Philip J Almeter Aaron N Hunter Thomas A Lyman Stephanie P Zapata | 2023 |
Variability in content of hydrocortisone sodium succinate | Contact in context | Margaret Felix James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter | 2023 |
Spectrometric analysis of dantrolene sodium | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2023 |
Quality variations in thyrotropin alfa | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2023 |
Spectrometric results of process variations in dacarbazine | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2022 |
Potential process control issues with pemetrexed | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2022 |
Variability in content of piperacillin and tazobactam injection | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2022 |
FDA approaches in monitoring drug quality, forces impacting the drug quality, and recent alternative strategies to assess quality in the US drug supply | Philip J Almeter James T Isaacs Aaron N Hunter Bradley S Henderson Thomas Platt | 2022/6 | |
FTNIR spectrometry of micafungin sodium quality | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2022 |
The Truth Is on the Shelves | Journal of Pharmaceutical Innovation | Philip J Almeter Robert A Lodder | 2022/6 |
Lack of content uniformity in MMR vaccine | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2022 |
The development of a novel pharmaceutical formulation of D-tagatose for spray-drying | Journal of Pharmaceutical Innovation | Heather R Campbell Fahd M Alsharif Patrick J Marsac Robert A Lodder | 2022/3 |
Levothyroxine variations by process analytical technology | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2022 |
Spectrometric analysis of process variations in remifentanil | Contact in context | James T Isaacs Philip J Almeter Bradley S Henderson Aaron N Hunter Thomas L Platt | 2022 |
A brief review of FDA’s novel tools for ensuring pharmaceutical quality in the human drug supply chain | Heather R Campbell Robert A Lodder | 2021/1 | |
36 Analysis of Vascular Tissue Using NIR Spectrometry | Robert A Lodder | 2021/5/19 | |
Potential process control issues with remdesivir | Contact in context | Philip J Almeter James T Isaacs Erin E Schuler Robert A Lodder | 2021 |
Co-Authors
